Literature DB >> 22309888

Human laboratory paradigms in alcohol research.

Jennifer G Plebani1, Lara A Ray, Meghan E Morean, William R Corbin, James MacKillop, Michael Amlung, Andrea C King.   

Abstract

BACKGROUND: Human laboratory studies have a long and rich history in the field of alcoholism. Human laboratory studies have allowed for advances in alcohol research in a variety of ways, including elucidating neurobehavioral mechanisms of risk, identifying phenotypically distinct subtypes of alcohol users, investigating the candidate genes underlying experimental phenotypes for alcoholism, and testing mechanisms of action of alcoholism pharmacotherapies on clinically relevant translational phenotypes, such as persons exhibiting positive-like alcohol effects or alcohol craving. Importantly, the field of human laboratory studies in addiction has progressed rapidly over the past decade and has built upon earlier findings of alcohol's neuropharmacological effects to advancing translational research on alcoholism etiology and treatment. METHODS AND
RESULTS: To that end, the new generation of human laboratory studies has focused on applying new methodologies, further refining alcoholism phenotypes, and translating these findings to studies of alcoholism genetics, medication development, and pharmacogenetics. The combination of experimental laboratory approaches with the recent developments in neuroscience and pharmacology has been particularly fruitful in furthering our understanding of the impact of individual differences in alcoholism risk and in treatment response.
CONCLUSIONS: This review of the literature focuses on human laboratory studies of subjective intoxication, alcohol craving, anxiety, and behavioral economics. Each section discusses opportunities for phenotype refinement under laboratory conditions, as well as its application to translational science of alcoholism. A summary and recommendations for future research are also provided.
Copyright © 2012 by the Research Society on Alcoholism.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22309888      PMCID: PMC4167612          DOI: 10.1111/j.1530-0277.2011.01704.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  128 in total

1.  Perceived family support, negative mood regulation expectancies, coping, and adolescent alcohol use: evidence of mediation and moderation effects.

Authors:  Salvatore J Catanzaro; Jeff Laurent
Journal:  Addict Behav       Date:  2004-12       Impact factor: 3.913

2.  Relative reinforcing efficacy of alcohol among college student drinkers.

Authors:  James G Murphy; James MacKillop
Journal:  Exp Clin Psychopharmacol       Date:  2006-05       Impact factor: 3.157

3.  Further validation of a cigarette purchase task for assessing the relative reinforcing efficacy of nicotine in college smokers.

Authors:  James MacKillop; James G Murphy; Lara A Ray; Daniel T A Eisenberg; Stephen A Lisman; J Koji Lum; David S Wilson
Journal:  Exp Clin Psychopharmacol       Date:  2008-02       Impact factor: 3.157

4.  Age and drinking-related differences in the memory organization of alcohol expectancies in 3rd-, 6th-, 9th-, and 12th-grade children.

Authors:  M E Dunn; M S Goldman
Journal:  J Consult Clin Psychol       Date:  1998-06

Review 5.  A neural substrate of prediction and reward.

Authors:  W Schultz; P Dayan; P R Montague
Journal:  Science       Date:  1997-03-14       Impact factor: 47.728

6.  The 'Trier Social Stress Test'--a tool for investigating psychobiological stress responses in a laboratory setting.

Authors:  C Kirschbaum; K M Pirke; D H Hellhammer
Journal:  Neuropsychobiology       Date:  1993       Impact factor: 2.328

7.  Anxiety sensitivity, self-reported motives for alcohol and nicotine use, and level of consumption.

Authors:  Amber Novak; Ellen S Burgess; Matthew Clark; Michael J Zvolensky; Richard A Brown
Journal:  J Anxiety Disord       Date:  2003

8.  Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study.

Authors:  Lara A Ray; Kent E Hutchison
Journal:  Arch Gen Psychiatry       Date:  2007-09

9.  Impulsivity (delay discounting) as a predictor of acquisition of IV cocaine self-administration in female rats.

Authors:  Jennifer L Perry; Erin B Larson; Jonathan P German; Gregory J Madden; Marilyn E Carroll
Journal:  Psychopharmacology (Berl)       Date:  2004-08-27       Impact factor: 4.530

10.  Does delay discounting play an etiological role in smoking or is it a consequence of smoking?

Authors:  Janet Audrain-McGovern; Daniel Rodriguez; Leonard H Epstein; Jocelyn Cuevas; Kelli Rodgers; E Paul Wileyto
Journal:  Drug Alcohol Depend       Date:  2009-05-14       Impact factor: 4.492

View more
  28 in total

Review 1.  Medications development for the treatment of alcohol use disorder: insights into the predictive value of animal and human laboratory models.

Authors:  Megan M Yardley; Lara A Ray
Journal:  Addict Biol       Date:  2016-02-01       Impact factor: 4.280

2.  Alcohol Craving and Consumption in Borderline Personality Disorder: When, Where, and with Whom.

Authors:  Sean P Lane; Ryan W Carpenter; Kenneth J Sher; Timothy J Trull
Journal:  Clin Psychol Sci       Date:  2016-03-15

3.  Further validation of a marijuana purchase task.

Authors:  Elizabeth R Aston; Jane Metrik; James MacKillop
Journal:  Drug Alcohol Depend       Date:  2015-05-11       Impact factor: 4.492

4.  Effects of Alcohol Cue Reactivity on Subsequent Treatment Outcomes Among Treatment-Seeking Individuals with Alcohol Use Disorder: A Multisite Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Varenicline.

Authors:  Robert Miranda; Stephanie S O'Malley; Hayley Treloar Padovano; Ran Wu; Daniel E Falk; Megan L Ryan; Joanne B Fertig; Thomas H Chun; Srinivas B Muvvala; Raye Z Litten
Journal:  Alcohol Clin Exp Res       Date:  2020-05-25       Impact factor: 3.455

5.  Differences between treatment-seeking and non-treatment-seeking participants in medication studies for alcoholism: do they matter?

Authors:  Lara A Ray; Spencer Bujarski; Megan M Yardley; Daniel J O Roche; Emily E Hartwell
Journal:  Am J Drug Alcohol Abuse       Date:  2017-04-20       Impact factor: 3.829

6.  GRIK1 and GABRA2 Variants Have Distinct Effects on the Dose-Related Subjective Response to Intravenous Alcohol in Healthy Social Drinkers.

Authors:  Bao-Zhu Yang; Albert J Arias; Richard Feinn; John H Krystal; Joel Gelernter; Ismene L Petrakis
Journal:  Alcohol Clin Exp Res       Date:  2017-11-13       Impact factor: 3.455

7.  A Pilot Study of the Safety and Initial Efficacy of Ivermectin for the Treatment of Alcohol Use Disorder.

Authors:  Daniel J O Roche; Megan M Yardley; Katy F Lunny; Stan G Louie; Daryl L Davies; Karen Miotto; Lara A Ray
Journal:  Alcohol Clin Exp Res       Date:  2016-04-18       Impact factor: 3.455

8.  Methods for inducing alcohol craving in individuals with co-morbid alcohol dependence and posttraumatic stress disorder: behavioral and physiological outcomes.

Authors:  Laura E Kwako; Melanie L Schwandt; Joanna R Sells; Vijay A Ramchandani; Daniel W Hommer; David T George; Rajita Sinha; Markus Heilig
Journal:  Addict Biol       Date:  2014-05-07       Impact factor: 4.280

9.  Effects of the opioid receptor antagonist naltrexone on smoking and related behaviors in smokers preparing to quit: a randomized controlled trial.

Authors:  Andrea King; Dingcai Cao; Lingjiao Zhang; Sandra Yu Rueger
Journal:  Addiction       Date:  2013-07-12       Impact factor: 6.526

10.  Associations of OPRM1 A118G and alcohol sensitivity with intravenous alcohol self-administration in young adults.

Authors:  Christian S Hendershot; Eric D Claus; Vijay A Ramchandani
Journal:  Addict Biol       Date:  2014-07-20       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.